Joint pain and arthritis
An individualized medical approach for people with pain, inflammation or restricted movement who want to understand which regenerative options may be considered within a joint health plan.
First, we understand the joint and how it is affecting your life
Joint pain can have multiple causes. That is why we do not select a therapy based solely on the symptom: we review the diagnosis, pain level, mobility, previous tests, treatments received and functional goals.
We review the intensity, duration and timing of pain, and whether stiffness or limitations affect everyday activities.
We aim to understand how the joint affects walking, exercise, work, sleep or daily activities.
Inflammation and the condition of the tissues around the joint may influence the selection of a plan.
Previous X-rays, MRI scans, ultrasound scans or other tests may help the doctor better understand the situation.
Approaches with different levels of evidence
The approaches described have different levels of evidence and are not equivalent. Evaluation distinguishes management measures supported by clinical guidelines from emerging or experimental interventions. Mentioning an intervention does not mean that it is authorized or indicated for your case.
Mesenchymal cells
Mesenchymal cells are being investigated for certain joint conditions. This does not establish that any cell product regenerates a joint or is safe and effective for arthritis. Before considering use, the clinical evidence, risks and authorizations for the product and procedure must be reviewed.
Their potential use is assessed based on the diagnosis, joint condition, medical history, previous treatments and the patient’s goals.
Learn more about mesenchymal cells →Platelet-Rich Plasma (PRP)
PRP is obtained from the patient’s own blood. Evidence and clinical recommendations vary by condition, joint and preparation. This does not establish effectiveness for every form of arthritis or guarantee regeneration.
The indication depends on the joint, diagnosis and medical assessment.
Exosomes and cell signaling
Exosomes are studied for their role in cell signaling. This research does not establish the safety and effectiveness of products offered for joint pain or arthritis. Any potential use requires specific clinical and regulatory review.
They may be evaluated in contexts related to joint health, chronic pain and inflammation, always considering product quality and the individual clinical case.
Learn about the secretome and exosomes →Ozone therapy
The available evidence on ozone therapy for arthritis is limited and does not justify treating it as an established treatment. Any potential use requires review of the evidence, risks, contraindications and authorizations applicable to the specific modality. Individual assessment does not replace that review.
In the joint context, a local modality may be considered or, depending on the assessment, other forms of administration.
Investigational peptides
The program includes bioactive peptides within its regenerative medicine area.
BPC-157 and TB-500 are discussed in research contexts. They should not be presented as established treatments for muscle, tendon or ligament injuries. Their safety and effectiveness for these uses are not established, and any proposal requires review of the evidence and the regulatory status of the specific product.
Comprehensive joint health plan
A single therapy is not always sufficient. The plan may include medical follow-up, adapted physical activity, weight management, nutrition and other strategies depending on the patient.
Modalities related to joint and tissue health
The medical program includes different forms of ozone therapy. Selection depends on the joint, clinical goal and individual evaluation.
Localized administration that may be considered in joints, tissues or other specific areas when the doctor determines there is an indication.
A systemic modality included in the ozone therapy program and selected only when the doctor considers its use appropriate.
We also assess muscles, tendons and ligaments
Pain does not always originate solely in cartilage or the joint itself. The surrounding tissues may also influence mobility, stability and function.
Injuries, overload and chronic changes may contribute to pain and functional limitations.
Joint stability and a history of injury are also part of the evaluation.
Strength, compensatory patterns and muscle function may influence how a joint tolerates movement and load.
The inflammatory context may be relevant when deciding which options are worth considering.
Functional goals, beyond a pain score
For some patients, the main goal is to regain walking tolerance or remain active.
Range of motion and stiffness may be as important as the pain level.
The goal may include gradually returning to physical activity or sports.
For other patients, the main goal is to preserve function and quality of life.
Treatment is determined after evaluation
We review the diagnosis, pain, mobility and medical history.
We analyze available test results and determine whether additional information is needed.
We decide which options, if any, make sense to consider: PRP, mesenchymal cells, exosomes, ozone or other strategies.
Functional progress is reviewed, and the plan may be adjusted based on the response.
Not everyone with arthritis needs the same approach
“Arthritis” and “joint pain” encompass different situations. Diagnosis, severity, age, tissue condition, previous treatments and functional goals are important before selecting an intervention.
Frequently asked questions
Which treatments do you use for joint pain and arthritis?
The page describes approaches with different levels of evidence. PRP recommendations depend on the diagnosis and preparation; cell products, exosomes, ozone therapy and investigational peptides require a separate review of evidence, risks and applicable authorizations. Mentioning them does not establish that they are appropriate or available for your case.
Does every patient receive mesenchymal cells?
No. Cell products are not a routine requirement for joint care. Research findings do not establish that a specific product is safe or effective for your diagnosis. Evidence, risks, alternatives and applicable authorizations require review before any proposal.
Do you use PRP for joints?
PRP is obtained from the patient’s own blood. Evidence and recommendations vary by condition, joint and preparation; it is not an established treatment for every form of arthritis and does not guarantee regeneration.
Do you also assess tendons and ligaments?
Yes. The evaluation may include muscles, tendons and ligaments when relevant to the pain. Mentioning investigational peptides does not establish their safety or effectiveness for these tissues.
Do these treatments guarantee joint regeneration?
No. Joint regeneration, cartilage repair or clinical improvement cannot be guaranteed. An individual evaluation does not replace evidence specific to the intervention, product and diagnosis.
Do I need tests before my evaluation?
If you already have X-rays, MRI scans, ultrasound scans or medical reports, they may be useful for the evaluation. The doctor will determine whether additional information is needed.
Tell us which joint hurts and how much it is limiting your life
Our team can review your situation and available test results, and explain which CellNova options may make sense to consider as part of an individual medical evaluation.
Educational information. The therapies described are not appropriate for everyone and do not guarantee regeneration or clinical improvement. The availability and suitability of any intervention depend on an individual medical evaluation. Results may vary from patient to patient.The approaches described do not have the same level of evidence. Cartilage regeneration or a cure for arthritis is not guaranteed. Evaluation must distinguish measures supported by clinical guidelines from emerging or experimental interventions and review their risks and alternatives.
The information on this page is educational and does not replace an individual medical evaluation. Evidence, risks and regulatory status vary by intervention, product and proposed use. Research on a biological mechanism does not by itself establish that a treatment is safe or effective. A cure, regeneration or specific clinical outcomes are not guaranteed. Decisions require review of the applicable evidence, risks, alternatives and informed consent.